Sr Director Strategic Technologies

Alnylam Pharmaceuticals Inc

Cambridge, MA

JOB DETAILS
SKILLS
Access Control, Amazon Web Services (AWS), Analysis Skills, Application Programming Interface (API), Architectural Services, Artificial Intelligence (AI), Biomarkers, Clinical Practices/Protocols, Cloud Computing, Computer Architecture, Computer Systems, Continuous Integration, Cross-Functional, Data Sets, Design Flows, Digital Photography, Disease, Drug Development, Drug Discovery, Ecosystems, Embedded Systems, Enterprise Protection, Genetic Research, Genetics, Genomics, High Throughput, Information Technology & Information Systems, Information/Data Security (InfoSec), Laboratory Information Management System (LIMS), Leadership, Maintain Compliance, Manufacturing, Manufacturing Requirements, Metadata, Ontology, Pathology, Pharmacovigilance, Pre-Clinical Development, Proteomics, Python Programming/Scripting Language, Quality Engineering, Quality Metrics, Regulations, Regulatory Requirements, Research & Development (R&D), SQL (Structured Query Language), Security Infrastructure, Snowflake Schema, Software Design, Structured Data, System Architecture, System Integration (SI), Technical Leadership, Technical Strategy, Technical Support, Translational Research
LOCATION
Cambridge, MA
POSTED
30+ days ago

Overview

Alnylam is seeking a deeply technical and strategic leader to serve as Senior Director Research & Early Development ReDev Technology. This role owns the domain-specific scientific systems architecture computational platforms and AI-enabled digital capabilities supporting TargetBiomarker Discovery RNAi Platform & Delivery Screening Lead Optimization DMPK Bioanalytics Investigative Sciences and Non-Clinical Safety.

This is a strategic technology leadership role that also requires meaningful architectural depth. The Senior Director must partner closely with Research & Early Development leaders at all levels while actively guiding domain system architecture integration patterns modern data design AI-enabled workflow modernization secure scientific computing environments and multi-omicsimaging data integration.

The role requires familiarity with large-scale human genetics and cohort datasets e.g. UK Biobank FinnGen NASHBio and the ability to design systems that enable their effective utilization for target discovery validation and translational research.

The Senior Director will serve as the IT representative within the Research & Early Development Leadership Team contributing to strategic discussions and ensuring digital priorities are tightly aligned with scientific and portfolio objectives.

The role also requires close collaboration with Clinical Development and CMC organizations to ensure discovery and preclinical digital capabilities are aligned with downstream clinical manufacturing and regulatory requirements - enabling seamless lifecycle data continuity from target discovery through clinical development and CMC readiness.

Shared lab execution platforms e.g. ELN LIMS are owned by the Lab-to-Product Platform & Operations organization. Enterprise data engineering and centralized AI platforms are owned by the Enterprise Data & AI organization. This role partners closely with both to ensure ReDev domain systems are integrated AI-ready and aligned with enterprise standards.

This hybrid role is based in Cambridge MA with regular engagement at our Cambridge headquarters.

Key Responsibilities

Own the ReDev Domain Architecture & Application Strategy

Define and govern the technical architecture across discovery and preclinical domain systems

Lead lifecycle management of applications supporting Molecular design and modeling RNAi delivery and screening platforms Digital pathology and imaging systems DMPK bioanalytics and nonclinical safety Omics spatial omics proteomics and high-throughput platforms

Enable effective integration and analysis of large-scale human genetics and cohort datasets e.g. UK Biobank FinnGen NASHBio

Ensure domain systems integrate effectively with shared ELNLIMS and enterprise data platforms

Partner on Domain Data Architecture & Snowflake Integration

Partner with Enterprise Data & AI to design domain data flows into Alnylams Snowflake-based enterprise data platform

Define domain data requirements for genomics proteomics spatial omics and imaging datasets

Enable structured data products for human genetics and translational research

Collaborate on metadata alignment ontology mapping and cross-cohort harmonization

Enterprise Data & AI owns core Snowflake platform engineering and infrastructure

Partner on Generative & Agentic AI-Enabled Scientific Systems

Partner with Enterprise Data & AI to design and operationalize AI-enabled workflows across discovery and preclinical domains

Apply generative AI to support hypothesis generation target identification and multi-omics interpretation

Architect agentic AI systems capable of orchestrating cross-dataset analyses e.g. cohort genetics proteomics imaging

Ensure AI capabilities are embedded into production scientific workflows

Enterprise Data & AI owns core AI platform engineering and model infrastructure

Architect Secure Scientific Computing & Trusted Research Environments

Design and operate Trusted Research Environments TREs to support secure analysis of sensitive human genetics and cohort data

Enable controlled-access environments for datasets such as UK Biobank FinnGen and NASHBio

Ensure compliance with privacy governance and regulatory standards

Partner with Enterprise Data Security and Infrastructure teams to align on enterprise security controls

Serve as Strategic & Technical Thought Partner

Act as primary IT representative to the Research & Early Development Leadership Team

Contribute to portfolio and target strategy discussions with a technology and data perspective

Translate scientific strategy into scalable digital and AI-enabled architecture

Represent IT in cross-functional and executive leadership forums

Partner with Clinical and CMC technology leaders to ensure discovery and preclinical systems enable translational continuity biomarker integration clinical readiness and downstream manufacturing alignment

Contribute to cross-functional lifecycle architecture discussions spanning ReDev Clinical and CMC

Required Qualifications

15 years of progressive IT leadership supporting drug discovery and preclinical development

Demonstrated architectural depth across complex scientific systems

Proven ability to partner effectively with senior scientific stakeholders

Experience operating within senior leadership forums e.g. R&D Leadership Teams with demonstrated executive presence

Human Genetics & Multi-Omics Expertise

Familiarity with large-scale population and cohort datasets such as UK Biobank FinnGen NASHBio

Demonstrated understanding of how these datasets are utilized for Target discovery and validation Rare variant association Translational research

Experience supporting or integrating Genomics and variant datasets Spatial omics platforms Proteomics datasets Imaging-genomics analyses

Domain Architecture & Data Engineering Fluency

Deep expertise in modern data engineering concepts ELTETL patterns Lakelakehouse architectures API-first integration Cloud-native data platforms

Experience integrating domain scientific systems with enterprise data platforms e.g. Snowflake in partnership with centralized teams

Advanced SQL and Python proficiency with production-quality engineering standards

AI & Secure Computing Experience

Demonstrated practical experience applying both generative AI and agentic AI in scientific or R&D environments

Experience operationalizing AI within production discovery workflows

Hands-on experience designing and implementing Trusted Research Environments TREs

Strong understanding of responsible AI and secure scientific computing

Preferred Qualifications

Experience with modern discovery and preclinical technology ecosystems including Digital Pathology & Imaging HALO HALO Link Patholytix Visiopharm Non-Clinical Safety & DMPK SEND environments Phoenix WinNonlin Bioanalytics Platforms Benchling Sapio Omics & Workflow Engines Paradigm4 DNAnexus AWS HealthOmics Nextflow High-Content Imaging Signals Image Artist

Experience in RNAi oligonucleotide or gene-modality platforms strongly preferred.

U.S. Pay Range

226800.00 - 306800.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including but not limited to relevant experience skills and education. This role is eligible for an annual short-term incentive award e.g. bonus or sales incentive and an annual long-term incentive award e.g. equity.

Alnylams robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical dental and vision coverage life and disability insurance a lifestyle reimbursement program flexible spending and health savings accounts and a 401kwith a generous company match. Eligible employees enjoy paid time off wellness days holidays and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website httpswww.alnylam.comcareers

About Alnylam

We are the leader in RNAi therapeutics - a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of whats possible. Our deep pipeline late-stage programs and bold vision reflect our core values fierce innovation passion for excellence purposeful urgency open culture and commitment to people. Were proud to be a globally recognized top employer where an authentic inclusive culture and breakthrough thinking fuel one another.

At Alnylam we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex gender or gender identity sexual orientation race color ethnicity national origin ancestry citizenship religion creed physical or mental disability pregnancy status or related conditions genetic information veteran or military status marital or familial status political affiliation age or any other factor protected by federal state or local law. Alnylam is an E-Verify Employer.

About the Company

A

Alnylam Pharmaceuticals Inc

Alnylam is leading the translation of RNAi as a new class of innovative medicines, with a core focus on RNAi therapeutics toward genetically defined targets for the treatment of serious, life-threatening diseases with limited treatment options for patients and their caregivers.
INDUSTRY
Healthcare Services
FOUNDED
2002
WEBSITE
http://www.alnylam.com/